Navigation Links
TGen and Virginia G. Piper Cancer Center form drug development collaboration with Cedars-Sinai
Date:11/8/2011

SCOTTSDALE, Ariz. -- The Virginia G. Piper Cancer Center at Scottsdale Healthcare is expanding its efforts to accelerate advances in cancer care with the addition of Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute in Los Angeles as a collaborator in clinical trials to develop personalized therapies that could lead to more effective cancer treatments.

The collaboration will focus on Phase I clinical trials of new personalized therapies for a variety of rare and common cancers, focusing on three areas of cancer research:

  • Gastrointestinal malignancies including pancreatic, colorectal and gastric cancer
  • Genitourinary malignancies such as prostate, kidney and bladder cancer
  • Rare cancers including adrenal, neuroendocrine and thyroid cancer

Virginia G. Piper Cancer Center Clinical Trials, a partnership between the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, will provide local coordination for the program. The partnership offers patients access to promising new cancer treatments through clinical trials, emphasizing collaboration among leading organizations to speed innovation from laboratory bench to patient bedside.

The collaborative endeavor between TGen, Virginia G. Piper Cancer Center and Cedars-Sinai also will study new approaches to improve patients' quality of life during cancer treatment and create innovative models to deliver supportive care and services to cancer survivors.

The Virginia G. Piper Cancer Center at Scottsdale Healthcare serves the greater Phoenix area with innovative cancer treatment and research facilities that attract patients from across Arizona and the United States.

"In addition to our local patients a significant number travel from the west coast for treatment at the Virginia G. Piper Cancer Center. The opportunity to expand our collective efforts against these cancers will undoubtedly mean progress in medicine's abili
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Virginia Commonwealth University findings may help explain high blood pressure in pregnancy
2. Virginia Commonwealth University study: We are what we experience
3. TGen/Virginia G. Piper Cancer Center publish results of new drug for pancreatic cancer patients
4. TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer
5. Months After Shootings, Many Virginia Tech Students Suffered PTSD
6. TGen, Virginia G. Piper Cancer Center studying new breast cancer drug
7. VCU Massey Cancer Center awarded $2.4 million grant from Virginia Tobacco Commission
8. Virginia Bioinformatics Institute to model immune responses to gut pathogens
9. Virginia Tech professor discovers new TB pathogen
10. VCU first Virginia institution to join national network of academic research centers
11. Dr. Phillip Chang Introduces New Ways to Decrease Scars and Potential Complications For Breast Augmentations in Loudoun and Fairfax Virginia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
(Date:4/17/2014)... estimated that as many as 10 million older Americans ... loneliness and isolation. , However, new research a ... older Americans for six years found that Internet ... depression by more than 30 percent. , "That,s a ... University professor of telecommunication, information studies and media who ...
(Date:4/17/2014)... a new mechanism that allows blood to enter the ... and the Salk Institute have opened the door to ... damage. , A complex and devastating neurological condition, stroke ... for disability in the U.S. The blood-brain barrier is ... into the brain, causing the permanent deficits in movement ...
(Date:4/17/2014)... Calif.) An international team led by researchers at ... complex, which plays a key role in cell division, ... This is the first time the complex has been ... make cyclin B1/Cdk1 an excellent target to control cellular ... The research was published online today in the journal ...
(Date:4/17/2014)... Population Council scientists and their partners have found that ... prevent the transmission of multiple sexually transmitted infections (STIs) ... herpes simplex virus 2 (HSV-2), and human papillomavirus (HPV). ... the gel is effective against multiple strains of HIV, ... against all three viruses of at least eight hours ...
Breaking Medicine News(10 mins):Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... National Dementia Screening Policy , , ... the nation faces a public health crisis related to ... the Alzheimer,s Foundation of America (AFA) disputes an ongoing ... The report shatters unsubstantiated criticism and instead emphasizes the ...
... Non-Contact Medical Device Innovations - the Future of Patient ... in Outer Space , , ... Noninvasive Medical Technologies, Inc. (NMT), a medical device company ... for military and civilian medical use, today announced that ...
... /PRNewswire-Asia-FirstCall/ -- China Shenghuo,Pharmaceutical Holdings, Inc. (NYSE Alternext ... that the Company is expanding its herbal-based,"12 Ways" ... markets in Mainland China. , ... its "12 Ways" brand of cosmetics products,to eleven ...
... PatentStorm, the searchable website of millions of U.S. patents, has expanded ... applications. PatentStorm has also completed a host of other improvements, making ... ... Washington, DC (PRWEB) December 9, 2008 -- PatentStorm ...
... China, Dec. 9 /PRNewswire-Asia-FirstCall/ -- China Sky One ... (Nasdaq: CSKI ), a leading,fully integrated ... of China ("PRC"), announced today that its subsidiary,Peng ... production approval from the State Food and Drug ...
... for Low-dose, Weekly Contraceptive Patch to be Presented at ACOG ... , PRINCETON, N.J., Dec. 9 Agile ... products, today announced that two abstracts from Phase 2 studies ... by the American College of Obstetricians and Gynecologists Annual ...
Cached Medicine News:Health News:New Study Disputes Ongoing Controversy Over Memory Screenings 2Health News:New Study Disputes Ongoing Controversy Over Memory Screenings 3Health News:New Study Disputes Ongoing Controversy Over Memory Screenings 4Health News:U.S. Air Force Awards Noninvasive Medical Technologies $2.4 Million Contract 2Health News:U.S. Air Force Awards Noninvasive Medical Technologies $2.4 Million Contract 3Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 2Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 3Health News:China Shenghuo Announces Additional Roll-Out of '12 Ways' Cosmetics Products to Watsons Stores 4Health News:PatentStorm Releases U.S. Patent Applications and Other Features 2Health News:China Sky One Medical, Inc. Obtains Production Rights for Two New Drugs 2Health News:China Sky One Medical, Inc. Obtains Production Rights for Two New Drugs 3Health News:Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG 2Health News:Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG 3Health News:Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG 4
(Date:1/15/2014)... , January 15, 2014 BreedIT Corp ... exclusive worldwide distributor of highly sophisticated agro-breeding solutions for ... 7, 2014, the Company,s board of directors appointed chemistry ... as its new member of the board. ...
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB ... composition of matter, biological targets, mechanism of action, methods ... This patent application describes a novel class ... which interfere with the basic homeostatic cellular processes in ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... Forecast – Worldwide Analysis ... Market Analysis Insulin ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... July 12 Endo Pharmaceuticals (Nasdaq: ENDP ) today ... offer by its wholly owned subsidiary, HT Acquisition Corp., for all ... HTRN).  American Stock Transfer & Trust Company, the depositary for the ... , New York City time, on July 9, ...
... 12 Signum Biosciences announced that its ... Medirepair® with Signum,s compound Arazine™ (n-acetyl-s-farnsylcysteine or AFC) ... compound from Signum,s novel anti-inflammatory platform to be ... (STMs). The DRx AFC Medirepair® website can be ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 2Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 3Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc. 4Signum Biosciences, Inc. Announces Commercial Launch of Arazine™ 2Signum Biosciences, Inc. Announces Commercial Launch of Arazine™ 3
... a simple click of the mouse ... mouse cursor to the desired position ... slide and the magnified image is ... Interface (GUI) enables one-click operation of ...
... new Eclipse TS100 is an ... microscope. This high quality tool ... mechanics and increased stability - ... rigid vibration resistant design that ...
Carbide drill bits, cutters, side cutting. Available in various sizes....
... the enclosed polaroid glasses, these polarized ... devise for near point stereopsis which ... perception, the images appear to pop ... test includes circle patterns for depth ...
Medicine Products: